FGFRL1 affects chemoresistance of small‐cell lung cancer by modulating the PI3K/Akt pathway via ENO1

Fibroblast growth factor receptor‐like 1 (FGFRL1), a member of the FGFR family, has been demonstrated to play important roles in various cancers. However, the role of FGFRL1 in small‐cell lung cancer (SCLC) remains unclear. Our study aimed to investigate the role of FGFRL1 in chemoresistance of SCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rui, Li, Deyu, Zheng, Meng, Chen, Bin, Wei, Ting, Wang, Yu, Li, Man, Huang, Weimei, Tong, Qin, Wang, Qi, Zhu, Yaru, Fang, Wei, Guo, Linlang, Fang, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011138/
https://www.ncbi.nlm.nih.gov/pubmed/31957179
http://dx.doi.org/10.1111/jcmm.14763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011138/
https://www.ncbi.nlm.nih.gov/pubmed/31957179
http://dx.doi.org/10.1111/jcmm.14763

Ejemplares similares